Peer-influenced content. Sources you trust. No registration required. This is HCN.

Medical News Today (MNT)2 Major Statins May Be Equally Effective at Preventing Stroke, Heart Attacks

Statins Show Equal Efficacy in Stroke and Heart Attack Prevention, but Differ in Side Effects

A recent study has found that two major statins, rosuvastatin and atorvastatin, are equally effective at reducing heart attacks, strokes, and all-cause deaths. However, the study also revealed that, although rosuvastatin lowers cholesterol more than atorvastatin, it carries a higher risk of developing diabetes and cataracts.

Key Points

  • The study involved 4,400 people in a trial conducted at 12 hospitals throughout South Korea.
  • Participants were administered either rosuvastatin or atorvastatin between September 2016 and November 2019.
  • The primary outcomes were heart attack, stroke, all-cause death, and the need for coronary revascularization.
  • For all of these outcomes, the two statins performed roughly equally.
  • The rosuvastatin group was more likely (7.2%) to develop type 2 diabetes than the atorvastatin group (5.3%).

According to a study published in JAMA Cardiology, taking a lower dose of the statin rosuvastatin alongside ezetimibe can be just as helpful as a higher dose of rosuvastatin when it comes to preventing cardiovascular deaths, hospitalization for cardiovascular events, and strokes.

More on Heart Attack/Myocardial Infarction

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form